Fig. 6

Subgroup analysis of patients with wall movement disorder or disturbed myocardial relaxation. N-terminal prohormone of brain natriuretic peptide (NT-proBNP) at day 2 (A) (CI of difference − 2063 to -138.0), ejection fraction (EF) (CI of difference 0.00 to 25.0) (B) and right ventricular end-diastolic diameter (RVEDD) at day 2 (C) (CI of difference − 12.00 to 0–00) in polytraumatized patients with wall movement disorder compared to patients without normal wall movement. 10 years cardiac risk score 2 (D) (CI of difference − 18.90 to -2.3), left ventricular end-diastolic diameter (LVEDD) (D) (CI of difference 0.00 to 15.00), troponin T concentration (TnT) at day 1 (F) (CI of difference − 543 to 0.00), NT-proBNP concentration at emergency room (ER) (G) (CI of difference − 370 to -5.0) or day1 (H) (CI of difference − 2267 to -25.0), as well as ejection fraction (EF) at day 1 (I) (CI of difference 0.0 to 30.0) and day 2 (J) in patients with disturbed vs. normal myocardial relaxation (CI of difference 5.0 to 30.0). *p ≤ 0.05, **p ≤ 0.01. Mann–Whitney test